SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-018669
Filing Date
2021-08-05
Accepted
2021-08-05 07:28:53
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1563779
2 ex31-1.htm EX-31.1 15164
3 ex31-2.htm EX-31.2 15296
4 ex32-1.htm EX-32.1 6026
5 ex32-2.htm EX-32.2 5987
  Complete submission text file 0001493152-21-018669.txt   5757821

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE prvb-20210630.xsd EX-101.SCH 40684
7 XBRL CALCULATION FILE prvb-20210630_cal.xml EX-101.CAL 50341
8 XBRL DEFINITION FILE prvb-20210630_def.xml EX-101.DEF 132733
9 XBRL LABEL FILE prvb-20210630_lab.xml EX-101.LAB 330380
10 XBRL PRESENTATION FILE prvb-20210630_pre.xml EX-101.PRE 248983
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 847770
Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38552 | Film No.: 211146322
SIC: 2834 Pharmaceutical Preparations